Skip to main content


Figure 3 | Clinical Proteomics

Figure 3

From: Proteomic analysis of human plasma in chronic rheumatic mitral stenosis reveals proteins involved in the complement and coagulation cascade

Figure 3

Biological network of reported proteins associated with Rheumatic Mitral Stenosis. Proteins marked by red circles indicate differentially abundant proteins. Proteins indicated by green circles have not been found to be differentially abundant in the proteomic phase but were found to be so in the verification phase of the study. AHSG, α-2-HS- glycoprotein; A2M,α-2-macroglobulin; ALB,albumin; APOA1,Apolipoprotein AI; APOC3,apolipoprotein CIII; CP,ceruloplasmin; CLU,clusterin; C3,complement component 3; C4A,complement component 4A; C4BPA,complement component 4 binding protein α; CFB,complement factor B; CFH,complement factor H; FGA,fibrinogen α chain; FGB,fibrinogen β chain; FGG,fibrinogen γ chain; HP,haptoglobin; HPR,haptoglobin related protein; IGHA1,Ig alpha-1 chain C region; IGHA2,Ig alpha-2 chain C region; IGHG1,Ig gamma-1chain C region (G1m marker); IGHG2,Ig gamma-2 chain C region (G2m marker); IGHG3,Ig gamma-3 chain C region (G3m marker); IGHG4,Ig gamma-4 chain C region (G4m marker); IGK@,Ig kappa chain C region; IGKV4-1,Ig kappa chain variable 4–1; IGLC1,Ig lambda-1chain C region; IGLC2,Ig lambda-2 chain C region; ORM1,orosomucoid 1 or α-1-acid glycoprotein 1; SERPIN A1,serpin peptidase inhibitor, clade A member 1 or α-1-antitrypsin; SERPIN A3,serpin peptidase inhibitor, clade A member 3 or α-1-antichymotrypsin; VTN,vitronectin

Back to article page